Orchid Pharma Share Price

Orchid Pharma

CMP as on 23-May-22 13:35

₹ 305.00
-5.30 -1.71%

Open

₹ 308.85

Turnover (lac)

₹ 21

Prev. Close

₹ 310.30

Day's Vol (shares)

₹ 6,831

Day's Range (₹)

₹ 292.00
₹ 310.85

CMP as on23-May-22 13:35

₹ 307.90
-3.1 -1%

Open

₹ 310.00

Turnover (lac)

₹ 4

Prev. Close

₹ 311.00

Day's Vol (shares)

₹ 2,010

Day's Range

₹ 296.00
₹ 311.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-May-2022 - -
Audited Results Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve the Audited financial results (Standalone and Consolidated) for the financial year ended March 31,2022 Outcome of Board meeting-May 12,2022-Approval of Audited financial results-March 31,2022 (As per BSE Announcement Dated on 12/5/2022)
Board Meeting - 05-Feb-2022 - -
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 inter alia to consider and approve the Unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended December 31 2021 Outcome of Board meeting held on February 12,2022 (As Per BSE Announcement Dated on 12.02.2022)
Board Meeting - 16-Dec-2021 - -
Disclosure under Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Regarding approval of Scheme of Amalgamation and Arrangement
Board Meeting - 08-Nov-2021 - -
Quarterly Results Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 202 (As Per BSE Announcement Dated on 14.11.2021)
Board Meeting - 01-Nov-2021 - -
Outcome of Board meeting held on November 01, 2021
Board Meeting - 06-Aug-2021 - -
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve Notification as per Listing Regulations- Notice of meeting of the Board of Directors August 13 2021 Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2021 (As per BSE Announcement Dated on 13/8/2021)
Board Meeting - 12-Jul-2021 - -
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2021 ,inter alia, to consider and approve Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice of meeting of the Board of Directors to be held on July 15, 2021 Outcome of Board meeting-July 15,2021 (As per BSE Announcement Dated on 15/7/2021) Revision in submission due to inadvertent typographical error- outcome of Board meeting dated July 15,2021 (As Per BSE Announcement dated on 16.07.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity